贸易债权人 更改
Alaunos Therapeutics USD 400K 213K 2026-03
Amgen USD 2.86B 16.65B 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Baxter International USD 1.03B 52M 2026-06
Biogen USD 403.9M 45.4M 2026-06
Bioline Rx USD 4.9M 331K 2026-03
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Celltrion KRW 88.58B 9.9B 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Curis USD 6.74M 1.13M 2026-03
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 6.39M 1.12M 2026-06
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Incyte USD 1.39B 1.16B 2026-06
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
J&J USD 9.22B 1.24B 2026-06
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Merck USD 3.83B 36M 2026-06
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Novartis USD 4.26B 64M 2026-06
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pfizer USD 4.58B 75M 2026-06
Pharma Mar EUR 38.93M 4.9M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Qiagen NV USD 79.08M 785K 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sartorius EUR 329.1M 16.2M 2026-06
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
TG Therapeutics USD 213.69M 64.85M 2026-06
Tilray USD 114.5M 3.69M 2025-09
Verastem USD 9.6M 2.85M 2026-03
Zealand Pharma A/S 171M 175.6M 2026-03
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03